These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9063449)

  • 1. The catalytic domain of activated collagenase I (MMP-1) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (TIMP-1).
    Vallon R; Müller R; Moosmayer D; Gerlach E; Angel P
    Eur J Biochem; 1997 Feb; 244(1):81-8. PubMed ID: 9063449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
    Will H; Atkinson SJ; Butler GS; Smith B; Murphy G
    J Biol Chem; 1996 Jul; 271(29):17119-23. PubMed ID: 8663332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of active recombinant TIMP-1 from Escherichia coli inclusion bodies and complex formation with the recombinant catalytic domain of PMNL-collagenase.
    Kleine T; Bartsch S; Bläser J; Schnierer S; Triebel S; Valentin M; Gote T; Tschesche H
    Biochemistry; 1993 Dec; 32(51):14125-31. PubMed ID: 8260495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases.
    Ogata Y; Itoh Y; Nagase H
    J Biol Chem; 1995 Aug; 270(31):18506-11. PubMed ID: 7629179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction.
    Knäuper V; Cowell S; Smith B; López-Otin C; O'Shea M; Morris H; Zardi L; Murphy G
    J Biol Chem; 1997 Mar; 272(12):7608-16. PubMed ID: 9065415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational study of the amino-terminal domain of human tissue inhibitor of metalloproteinases 1 (TIMP-1) locates an inhibitory region for matrix metalloproteinases.
    Huang W; Meng Q; Suzuki K; Nagase H; Brew K
    J Biol Chem; 1997 Aug; 272(35):22086-91. PubMed ID: 9268350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between tissue inhibitor of metalloproteinases-2 and progelatinase A: immunoreactivity analyses.
    Fujimoto N; Ward RV; Shinya T; Iwata K; Yamashita K; Hayakawa T
    Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):827-33. PubMed ID: 8611162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B.
    O'Connell JP; Willenbrock F; Docherty AJ; Eaton D; Murphy G
    J Biol Chem; 1994 May; 269(21):14967-73. PubMed ID: 8195131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y; Yeon J; Kim HJ; Lee ST
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase.
    Itoh Y; Nagase H
    J Biol Chem; 1995 Jul; 270(28):16518-21. PubMed ID: 7622455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1.
    Crabbe T; Zucker S; Cockett MI; Willenbrock F; Tickle S; O'Connell JP; Scothern JM; Murphy G; Docherty AJ
    Biochemistry; 1994 May; 33(21):6684-90. PubMed ID: 7911325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
    Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
    Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases.
    Remacle AG; Shiryaev SA; Radichev IA; Rozanov DV; Stec B; Strongin AY
    J Biol Chem; 2011 Jun; 286(23):21002-12. PubMed ID: 21518756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of a novel recombinant myoglobin fusion protein expression system to characterize the tissue inhibitor of metalloproteinase (TIMP)-4 and TIMP-2 C-terminal domain and tails by mutagenesis. The importance of acidic residues in binding the MMP-2 hemopexin C-domain.
    Kai HS; Butler GS; Morrison CJ; King AE; Pelman GR; Overall CM
    J Biol Chem; 2002 Dec; 277(50):48696-707. PubMed ID: 12374789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragments of human fibroblast collagenase: interaction with metalloproteinase inhibitors and substrates.
    Bigg HF; Clark IM; Cawston TE
    Biochim Biophys Acta; 1994 Sep; 1208(1):157-65. PubMed ID: 8086430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules.
    Ohuchi E; Imai K; Fujii Y; Sato H; Seiki M; Okada Y
    J Biol Chem; 1997 Jan; 272(4):2446-51. PubMed ID: 8999957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway.
    Morrison CJ; Butler GS; Bigg HF; Roberts CR; Soloway PD; Overall CM
    J Biol Chem; 2001 Dec; 276(50):47402-10. PubMed ID: 11584019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.